Bioregenx (BRGX) Capital Expenditures (2024 - 2025)
Bioregenx's quarterly Capital Expenditures came in at $3057.0 in Q4 2025, down 49.05% quarter-over-quarter from $6000.0 in Q3 2025.
Bioregenx has reported Capital Expenditures for 2 years, with the latest figure at $3057.0 in Q4 2025.
- For the quarter ending Q4 2025, Capital Expenditures changed N/A year-over-year to $3057.0; the trailing twelve-month figure through Dec 2025 stood at $9057.0 (down 95.22% YoY), and the FY2025 full-year result was $9057.0, down 95.22% from the prior year.
- Capital Expenditures for Q4 2025 stood at $3057.0, down from $6000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $189390.0 in Q1 2024, with the low at $3057.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 7.03 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 3.67 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 15.93 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 28,000.00 |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 2.25 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 15.33 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 118,000.00 |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 12.44 Mn |
| 10 | Bioregenx | - | - | 348,288.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,057.00 |
| Dec 31, 2025 | 3,057.00 |
| Sep 30, 2025 | 6,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Mar 31, 2024 | 189,390.00 |
| Mar 31, 2024 | 189,390.00 |